<DOC>
	<DOCNO>NCT00832741</DOCNO>
	<brief_summary>The purpose study investigate whether secretion incretin hormone intact extent endogenous well exogenous GLP-1 control postprandial glucose excursion patient type-1 diabetes mellitus .</brief_summary>
	<brief_title>Incretin Hormones Type-1 Diabetes Mellitus Glycemic Response Type-1 Diabetes Mellitus</brief_title>
	<detailed_description>GLP-1 GIP incretin hormone secrete specific endocrine celles gut . Stimulus secretion prescence carbohydrate , fat protein gut . The incretin hormones control postprandial glucose excursion stimulation insulinsecretion well inhibition glucagon gastric emptying.The effect GLP-1 insulin secretion glucagon inhibition glucose dependent risc hypoglycemia therefore negligible hormone administer supra physiological concentrations.Furthermore , animal study suggest GLP-1 trofic effect betacells hormone show replenish intracellular store insulin . Because main bloodglucose lower effect GLP-1 thought due increase insulin secretion , analouges hormone develop treatment type-2 diabetes . So far , relatively little known effect GLP-1 type-1 diabetes.It possible , GLP-1 combination insulin ( possibly mainly effect glucagon inhibition gastric emptying ) could reduce need exogenous insulin concomitant reduce risc hypoglycemia . Without compromise target glucemic control . This study focus postprandial bloodglucose lower effect endogenous well exogenous GLP-1 patient type-1 diabetes accord residual betacell function glycemic control.Furthermore , endogenous secretion incretin hormones patient type-1 diabetes mellitus compare match normal control .</detailed_description>
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 1</mesh_term>
	<mesh_term>Hormones</mesh_term>
	<mesh_term>Gastric Inhibitory Polypeptide</mesh_term>
	<mesh_term>Incretins</mesh_term>
	<criteria>type1 diabetes mellitus diagnosis 540 year . age 1860 year normal weight time diagnosis insulintreatment diagnosis HbA1c &lt; 7.6 % diabetic complication disease type1 diabetes</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>60 Years</maximum_age>
	<verification_date>January 2009</verification_date>
	<keyword>GLP-1</keyword>
	<keyword>Type 1 diabetes</keyword>
	<keyword>Glycemic control</keyword>
	<keyword>Incretin hormone</keyword>
</DOC>